Small Pharma Granted Fast-Track Designation From U.K. Regulator for DMT-Assisted Therapy for Major Depressive Disorder Oct 21, 2021
BevCanna Announces Amendment to Health Canada Research License, Allowing Sensory Evaluations Within Product Development… Oct 20, 2021
atai Life Sciences Launches atai Impact, a Philanthropic Program to Harness the Power of Innovative Mental Health… Oct 19, 2021
PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products Oct 19, 2021
